These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1273949)

  • 1. [Treatment of generalized scleroderma with connective tissue inhibitors].
    Asboe-Hansen G
    Ugeskr Laeger; 1976 May; 138(22):1325-9. PubMed ID: 1273949
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of generalized scleroderma with inhibitors of connective tissue formation.
    Asboe-Hansen G
    Acta Derm Venereol; 1975; 55(6):461-5. PubMed ID: 55038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of generalized scleroderma: updated results.
    Asboe-Hansen G
    Acta Derm Venereol; 1979; 59(5):465-7. PubMed ID: 93375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of various collagen diseases based on connective tissue metabolism--with special reference to systemic scleroderma].
    Sasaki M
    Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(12):774-7. PubMed ID: 304922
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prognosis and treatment of scleroderma].
    Crickx B; Belaich S
    Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [D-penicillamine in the treatment of progressive systemic sclerosis].
    Marques Neto JF; Manzato LC; Samara AM
    AMB Rev Assoc Med Bras; 1980 Jun; 26(6):191-3. PubMed ID: 6970374
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systemic sclerosis in childhood].
    Falcini F; Trapani S; Taccetti G; Tafi L
    Pediatr Med Chir; 1990; 12(6):593-9. PubMed ID: 2093880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Penicillamine in the treatment of scleroderma].
    Kobíková M; Stáva Z
    Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of generalized scleroderma with inhibitors of collagen synthesis.
    Asboe-Hansen G
    Int J Dermatol; 1982 Apr; 21(3):159-61. PubMed ID: 7085173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of urinary acid glycosaminoglycan and collagen metabolite excretion with disease activity in generalized scleroderma.
    Blumenkrantz N; Asboe-Hansen G
    Acta Derm Venereol; 1980; 60(1):39-43. PubMed ID: 6153832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiological study of systemic scleroderma in Tokyo based on application forms for financial aid for patients with intractable diseases].
    Takehara K; Iozumi K; Mori S
    Nihon Hifuka Gakkai Zasshi; 1988 Dec; 98(14):1475-82. PubMed ID: 3251057
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effect of d-penicillamine in scleroderma].
    Bogdanikowa B; Rudy J; Bernacka K; Palka Z
    Pol Tyg Lek; 1973 Aug; 28(34):1317-20. PubMed ID: 4756401
    [No Abstract]   [Full Text] [Related]  

  • 13. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)].
    Böni A; Pavelka K; Kludas M
    Munch Med Wochenschr; 1969 Aug; 111(31):1580-4. PubMed ID: 5394493
    [No Abstract]   [Full Text] [Related]  

  • 15. Avocado/soybean unsaponifiables in the treatment of scleroderma: comment on the article by Maheu et al.
    Jablonska S
    Arthritis Rheum; 1998 Sep; 41(9):1705. PubMed ID: 9751109
    [No Abstract]   [Full Text] [Related]  

  • 16. [Scleroderma presenting as oedema (authors transl)].
    Godeau P; Bletry O; Teillac D; Herreman G; Wechsler B
    Nouv Presse Med; 1977 Dec; 6(43):4039-43. PubMed ID: 600750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Penicillamine in the treatment of patients with systemic scleroderma].
    Gandzha IM
    Vrach Delo; 1987 May; (5):66-7. PubMed ID: 3617690
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience using d-penicillamine in systemic scleroderma].
    Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP
    Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of systemic scleroderma with D-penicillamine. Results in 14 patients treated for more than a year].
    Kahn MF; Bourgeois P; Brion N; Elleuch M
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):35-8. PubMed ID: 3704510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [D-penicillamine therapy of chronic polyarthritis].
    Günther R; Gabl F; Knapp E
    Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.